Improving NK Cell Immunotherapy through Metabolic Conditioning
At a Glance
The project, Improving NK Cell Immunotherapy through Metabolic Conditioning, led by Jose Ayuso, PhD, aims to develop a more scalable and cost-effective immunotherapy for advanced melanoma using memory-like Natural Killer (ML-NK) cells. With more than 2,000 new melanoma cases diagnosed annually in Wisconsin, there is an urgent need for treatments that are both effective and accessible. Current immunotherapies, while promising, are often limited by high cost and logistical challenges. This initiative focuses on improving ML-NK cell function through targeted metabolic conditioning to create an “off-the-shelf” therapy that is affordable, durable and readily deployable. Collaborators include Christian Capitini, MD, professor, Department of Pediatrics, and Nihal Ahmad, PhD, professor and vice chair for research, Department of Dermatology.
